Development, Top Corporate Groups

Bangladesh received two million doses of COVID-19 vaccine from India in February. According to the health authorities, Bangladesh will receive another five million doses in last week of March or in first week of April. That will be the third consignment. The agreement between India’s Serum Institute and Bangladesh’s Beximco Pharma states that in total there will be six-instalment delivery. Country's top pharmaceuticals manufacturer, Beximco Pharma, is acquiring the Covid-19 vaccine on behalf of the Bangladesh government. This vaccine was developed jointly by UK’s Oxford University and AstraZeneca. Serum Institute of India is the manufacture. According to the agreement, 30 million doses will come to Bangladesh.

Bangladesh received first consignment of the vaccine on January 25. There were five million doses in the first consignment. Before that, on 21 January, Indian government sent two million doses to Bangladesh as a gift.

The second consignment arrived in the country on 23 February.

Till date, around 4.8 million people in Bangladesh received the first dose of the vaccine.

Bangladesh in a way stood out when it came to COVID-19 vaccination issue. Other countries were struggling to ensure vaccine, but Bangladesh got it on the earliest time. It was mainly possible for farsightedness of Salman F Rahman and Beximco Pharma. They acted strategically and successfully.